Recombinant Human Apo-2 Ligand For

Non-small-cell Lung Cancer (NSCLC) Stage IV

Shanghai Gebaide Biotechnology Co., Ltd.Phase 3

—

Rating in progress

Recombinant Human Apo-2 Ligand For in Non-small-cell Lung Cancer (NSCLC) Stage IV is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant